全球生物净化市场规模（按产品类型、代理、最终用户、区域范围和预测）

生物净化市场规模与预测

2024 年生物净化市场规模为 1.4983 亿美元，预计到 2032 年将达到 2.0854 亿美元，2026 年至 2032 年的复合年增长率为 4.22%。

生物去污是消除微生物污染或将微生物污染降低到可接受水平的过程。在各种环境中，生物去污都至关重要，因为细菌的存在会对健康造成严重危害。

生物去污是在隔离室、重症监护室和手术室等医院环境中进行的，以防止病原体的传播。

此外，製药和生物技术公司也使用它来确保产品纯度和员工安全。

全球生物净化市场动态

影响生物净化市场的关键市场动态是：

关键市场驱动因素

医疗相关感染 (HAI) 的增加：HAI 的增加是生物净化市场的主要驱动力。根据美国疾病管制与预防中心 (CDC) 的数据，每 31 名住院患者中就有 1 名每天至少患有一次医疗相关感染。这些高发病率凸显了医疗保健环境中强大的生物净化解决方案对于限制疾病传播和确保患者安全的关键性。

製药和生物技术产业的成长：製药和生物技术产业的成长增加了对生物净化服务和产品的需求。 FDA 报告称，2022 年核准了37 种创新药物，显示该产业正在持续扩张和创新。这种增长与对无菌工业环境和污染控制方法的需求不断增加直接相关，从而推动了生物净化市场的发展。

严格的监管标准：许多行业对清洁度和无菌度的严格规定正在推动生物净化市场的发展。例如，欧洲药品管理局（EMA）将于2024年8月实施欧盟GMP附件1，为无菌医疗产品的生产制定详细规则。该规则强调了采取污染预防措施的必要性，并鼓励使用先进的生物去污技术和服务。

主要问题

高成本：生物净化技术和服务的成本高，包括设备和基础设施的初始投资，限制了其采用，特别是在资源贫乏的环境和开发中国家。这种成本障碍阻碍了这些重要净化方法的广泛使用。

缺乏认识：在某些地方，人们缺乏对生物去污的重要性和好处的认识，导致采用率低。教育最终用户并强调保持清洁卫生环境的重要性对于克服这一限制至关重要。

病原体抗药性的多变性：不同感染疾病的抗药性水平会影响生物净化程序的有效性，从而难以确保一致、准确的净化结果。解决这种变化对于持续的市场发展至关重要。

主要趋势

过氧化氢蒸气(HPV) 技术的应用日益广泛：HPV 因其对多种细菌的有效性、材料相容性以及能够到达难以触及的地方而越来越受欢迎。製造商正致力于开发便携式、易于使用的 HPV 消毒设备。

製药业对生物净化的需求不断增长：製药业是生物净化技术的主要用户，以确保製造设施、设备和成品的无菌性。生技药品和先进药物的兴起正在推动对有效清洗技术的需求。

更重视医疗保健中的预防措施和感染控制：医疗保健产业正在专注于预防措施和感染控制，以减少医疗保健相关感染 (HAI) 的数量。生物去污对于维持医院的无菌环境至关重要，尤其是重症监护室和手术室。

目录

第一章 引言

• 市场定义
• 市场区隔
• 调查方法

第二章执行摘要

• 主要发现
• 市场概览
• 市集亮点

第三章市场概述

• 市场规模和成长潜力
• 市场趋势
• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析

第四章 生物净化市场（依产品）

• 装置
• 耗材

第五章 生物去污市场（按药剂）

• 过氧化氢
• 二氧化氯
• 过氧乙酸
• 二氧化氮

第六章。按类型分類的生物净化市场

• 腔室净化
• 房间净化

第七章 生物净化市场（依最终用户）

• 製药和医疗设备製造商
• 契约製造和研究机构
• 医院医疗保健设施
• 其他的

第八章区域分析

• 北美洲
• 美国
• 加拿大
• 墨西哥
• 欧洲
• 英国
• 德国
• 法国
• 义大利
• 亚太地区
• 中国
• 日本
• 印度
• 澳洲
• 拉丁美洲
• 巴西
• 阿根廷
• 智利
• 中东和非洲
• 南非
• 沙乌地阿拉伯
• 阿拉伯聯合大公国

第九章市场动态

• 市场驱动因素
• 市场限制
• 市场机会
• COVID-19 市场影响

第十章 竞争格局

• 主要企业
• 市场占有率分析

第十一章 公司简介

• STERIS（美国）
• Bioquell (Ecolab) (英国)
• JCE BIoTechnology（法国）
• Fedegari Autoclavi SpA（义大利）
• TOMI环境解决方案公司（美国）

第十二章 市场展望市场展望与机会

• 新兴技术
• 未来市场趋势
• 投资机会

第十三章 附录

• 简称列表
• 来源和参考文献

Bio Decontamination Market Size and Forecast

Bio Decontamination Market size was valued at USD 149.83 Million in 2024 and is projected to reach USD 208.54 Million by 2032, growing at a CAGR of 4.22% from 2026 to 2032.

Bio decontamination is the process of eliminating or lowering microbial contamination to a tolerable level. It is critical in a variety of settings where the presence of germs might offer serious health hazards.

Bio decontamination is used in hospital environments such as isolation rooms, critical care units, and operating theaters to avoid the transmission of pathogens.

Furthermore, it is also utilized in pharmaceutical and biotechnology companies to ensure product purity and employee safety.

Global Bio Decontamination Market Dynamics

The key market dynamics that are shaping the bio decontamination market include:

Key Market Drivers

Increasing Healthcare-Associated Infections (HAIs): The increased number of HAIs is a primary driver of the bio decontamination market. According to the Centers for Disease Control and Prevention (CDC), one in every 31 hospital patients contracts at least one healthcare-associated infection on any given day. This high incidence highlights the crucial need for robust bio decontamination solutions in healthcare settings to limit the spread of illnesses and ensure patient safety.

Growing Pharmaceutical and Biotechnology Industries: The growth of the pharmaceutical and biotechnology industries is increasing the demand for bio decontamination services and products. The FDA reported that 37 innovative medications were approved in 2022, demonstrating the industry's ongoing expansion and innovation. This rise is directly related to an increased demand for sterile industrial environments and contamination control methods, which is driving the bio decontamination market.

Stringent Regulatory Standards: Stricter restrictions on cleanliness and sterility in many industries are driving the bio decontamination market ahead. For instance, the European Medicines Agency (EMA) implemented EU GMP Annex 1 in August 2024, which establishes detailed rules for the production of sterile medical goods. This rule highlights the necessity of contamination control measures, which encourages the use of sophisticated bio decontamination technology and services.

Key Challenges:

High Cost: The high cost of bio decontamination technologies and services, including the initial investment in equipment and infrastructure, restricts uptake, particularly in resource-constrained settings and developing countries. This cost barrier prevents the widespread adoption of these crucial decontamination methods.

Lack of Awareness: In some locations, there is a lack of awareness regarding the importance and benefits of bio decontamination, resulting in lower adoption rates. Educating end users and stressing the importance of keeping clean and sanitary settings is critical for overcoming this constraint.

Variability in Pathogen Resistance: Different infections' resistance levels affect the efficacy of bio decontamination procedures, making it difficult to ensure consistent and accurate decontamination results. Addressing this variability is critical to the market's continued development.

Key Trends:

Increasing Adoption of Hydrogen Peroxide Vapor (HPV) Technology: HPV is gaining popularity due to its efficiency against a wide spectrum of germs, material compatibility, and ability to reach inaccessible locations. Manufacturers are concentrating on creating portable and user-friendly HPV disinfection equipment.

Growing Demand for Bio Decontamination in the Pharmaceutical Industry: The pharmaceutical business is a major user of bio decontamination technology to ensure the sterility of manufacturing facilities, equipment, and finished goods. The growth of biologics and sophisticated medicines is increasing the demand for effective cleaning technologies.

Increasing Focus on Preventive Measures and Infection Control in Healthcare: The healthcare industry is focusing on preventative measures and infection control to lower the number of healthcare-associated infections (HAIs). Bio decontamination is vital for maintaining a sterile environment in hospitals, particularly critical care units and operating rooms.

Global Bio Decontamination Market Regional Analysis

Here is a more detailed regional analysis of the bio decontamination market:

North America:

According to Verified Market Research, North America is estimated to dominate during the forecast period. North America, particularly the United States, leads in healthcare spending, resulting in increased investment in advanced bio decontamination technologies. According to the Centers for Medicare & Medicaid Services (CMS), U.S. healthcare spending will total $4.3 trillion in 2021, accounting for 18.3% of the country's GDP. This significant investment promotes the use of cutting-edge bio decontamination solutions in healthcare facilities throughout the region.

North America has some of the strictest rules for cleanliness and sterility in healthcare and pharmaceutical facilities. The United States Food and Medication Administration (FDA) said that in fiscal year 2022, it conducted over 3,000 inspections of human medication manufacturing plants to ensure compliance with good manufacturing standards. This regulatory pressure promotes the market for effective bio-decontamination goods and services to meet these high standards.

Furthermore, North America has a large biotechnology and pharmaceutical industry, which necessitates severe bio decontamination protocols. According to the Pharmaceutical Research and Manufacturers of America (PhRMA), the US biopharmaceutical industry invested an estimated $102.3 billion in research and development in 2021. This significant investment and expansion in the sector is directly related to an increased demand for bio decontamination solutions to maintain sterile research and manufacturing environments.

Asia Pacific:

The Asia Pacific region is estimated to exhibit the highest growth during the forecast period. The Asia Pacific region is rapidly expanding its healthcare facilities, resulting in increased demand for bio decontamination services and goods. According to the Asian Development Bank, healthcare spending in the Asia-Pacific region is expected to reach USD 2.4 Trillion by 2032, expanding at a CAGR of 6.3% between 2014 and 2032. This significant investment in healthcare infrastructure demands cutting-edge bio decontamination solutions to maintain sterile surroundings and avoid illness.

The increased incidence of HAIs in the region is a significant driver of the bio decontamination market. According to a study published in the Lancet Global Health, the prevalence of HAIs in Southeast Asia is over 9.0%, much higher than the global average of 7.6%. The high incidence emphasizes the urgent need for effective bio decontamination measures in healthcare settings across the Asia Pacific region.

Furthermore, the fast growth of the pharmaceutical and biotechnology sectors in the Asia Pacific is driving up demand for bio decontamination products and services. According to the India Brand Equity Foundation (IBEF), the Indian pharmaceutical sector alone is anticipated to be worth USD 130 Billion by 2032, increasing at a 12.3% CAGR. Similarly, McKinsey & Company estimates that China's pharmaceutical market would approach USD $300 Billion by 2025. This exponential rise in these industries needs strict contamination control methods, which is driving the regional bio decontamination market.

Europe:

Europe region is estimated to exhibit substantial growth during the forecast period. Europe's aging population is increasing the demand for healthcare services, which in turn raises the demand for bio decontamination in medical institutions. According to Eurostat, the proportion of adults 65 and older in the EU is expected to rise from 20.8% in 2021 to 31.3% by 2100. This demographic transition is projected to increase hospital admissions and medical treatments, needing strict bio decontamination measures to prevent healthcare-associated infections.

Europe has enacted stringent cleanliness and sterility rules in a variety of industries, most notably healthcare and pharmaceuticals. For example, the European Union's Good Manufacturing Practice (GMP) guidelines, which include the recently amended Annex 1 for sterile pharmaceutical products, establish stringent contamination control requirements. The European Medicines Agency (EMA) reported that in 2022, it recommended 89 medicines for marketing authorization, all of which must comply with these stringent bio decontamination standards.

Furthermore, Europe has a booming pharmaceutical and biotechnology industry, which is a major driver of the bio decontamination market. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the pharmaceutical industry invested around €44.5 billion in R&D in Europe in 2022. This significant investment in R&D demands modern bio decontamination solutions to provide sterile environments for medication development and manufacturing activities.

Global Bio Decontamination Market: Segmentation Analysis

The Bio Decontamination Market is segmented based on Product, Type, Agent, End-User, and Geography.

Bio Decontamination Market, By Product

• Equipment
• Consumables

Based on Product, the market is segmented into Equipment and Consumables. The equipment segment is estimated to dominate the bio decontamination market. This segment includes devices like hydrogen peroxide vaporizers, chlorine dioxide generators, and peracetic acid systems, which are essential for disinfecting and sterilizing surfaces, equipment, and environments in a variety of industries, including healthcare, pharmaceuticals, and biotechnology. The increased demand for this equipment reflects the growing requirement for effective bio-decontamination solutions to minimize illness transmission and assure product safety.

Bio Decontamination Market, By Type

• Chamber Decontamination
• Room Decontamination

Based on Type, the Bio Decontamination market is segmented into Chamber Decontamination and Room Decontamination. The chamber decontamination segment is estimated to dominate the market over the forecast period due to the widespread adoption of chamber-based bio decontamination systems in pharmaceutical, biotechnology, and research laboratories. These enclosed chambers provide regulated and effective decontamination of equipment, tools, and other key infrastructure, making them the ideal method for maintaining sterile workplaces in high-risk industries.

Bio Decontamination Market, By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

Based on Agent, the market is divided into Hydrogen Peroxide, Chlorine Dioxide, Peracetic Acid, and Nitrogen Dioxide. The hydrogen peroxide segment is estimated to dominate the global market. Hydrogen peroxide is used because it is efficient against a wide range of microorganisms, including spores, and may permeate surfaces and equipment. The advantages of hydrogen peroxide over other agents, such as its quick action, low toxicity, and ease of monitoring, are responsible for the segment's dominance in the bio decontamination market.

Bio Decontamination Market, By End-User

• Pharmaceutical and Medical Device Manufacturers
• Contract Manufacturing and Research Organizations
• Hospital and Healthcare Facilities
• Others

Based on End-User, the market is segmented into Pharmaceutical & Medical Device Manufacturers, Contract Manufacturing & Research Organizations, Hospital & Healthcare Facilities, and Others. The pharmaceutical & medical device manufacturers segment is estimated to dominate this segment in the forecast period due to the strict regulatory standards imposed by agencies, which need cleaning and sterilizing operations to prevent product contamination. The growing frequency of product recalls due to contamination issues has spurred the use of bio decontamination solutions by pharmaceutical and medical device makers to maintain product quality and safety.

Bio Decontamination Market, By Geography

• North America
• Europe
• Asia Pacific
• Rest of the World

Based on Geography, the bio decontamination market is classified into North America, Europe, Asia Pacific, and the Rest of the World. North America is estimated to dominate the bio decontamination market during the forecast period due to the healthcare sector's rapid expansion, rising occurrences of hospital-acquired illnesses, an aging population, and increased government programs and investments in healthcare facility sanitation.

Key Players

• The "Bio Decontamination Market" study report will provide valuable insight with an emphasis on the global market. The major players in the market are STERIS (U.S.), Bioquell (Ecolab) (U.K.), JCE Biotechnology (France), Fedegari Autoclavi S.p.A. (Italy), and TOMI Environmental Solutions, Inc. (U.S.).

Our market analysis also entails a section solely dedicated to such major players wherein our analysts provide an insight into the financial statements of all the major players, along with its product benchmarking and SWOT analysis. The competitive landscape section also includes key development strategies, market share, and market ranking analysis of the above-mentioned players globally.

• Bio Decontamination Market Recent Developments
• In July 2024, Ecolab's Bioquell HPV-AQ was granted authorization for use in all European Union and European Economic Area territories.
• In December 2024, TOMI Environmental Solutions, Inc. introduced new SteraMist products, including the Select Plus, a hybrid solution that combines the company's current Surface Select and Environment systems.

TABLE OF CONTENTS

1. Introduction

• Market Definition
• Market Segmentation
• Research Methodology

2. Executive Summary

• Key Findings
• Market Overview
• Market Highlights

3. Market Overview

• Market Size and Growth Potential
• Market Trends
• Market Drivers
• Market Restraints
• Market Opportunities
• Porter's Five Forces Analysis

4. Bio Decontamination Market, By Product

• Equipment
• Consumables

5. Bio Decontamination Market, By Agent

• Hydrogen Peroxide
• Chlorine Dioxide
• Peracetic Acid
• Nitrogen Dioxide

6. Bio Decontamination Market, By Type

• Chamber Decontamination
• Room Decontamination

7. Bio Decontamination Market, By End User

• Pharmaceutical and Medical Device Manufacturers
• Contract Manufacturing and Research Organizations
• Hospital and Healthcare Facilities
• Others

8. Regional Analysis

• North America
• United States
• Canada
• Mexico
• Europe
• United Kingdom
• Germany
• France
• Italy
• Asia-Pacific
• China
• Japan
• India
• Australia
• Latin America
• Brazil
• Argentina
• Chile
• Middle East and Africa
• South Africa
• Saudi Arabia
• UAE

9. Market Dynamics

• Market Drivers
• Market Restraints
• Market Opportunities
• Impact of COVID-19 on the Market

10. Competitive Landscape

• Key Players
• Market Share Analysis

11. Company Profiles

• STERIS (U.S.)
• Bioquell (Ecolab) (U.K.)
• JCE Biotechnology (France)
• Fedegari Autoclavi S.p.A. (Italy)
• TOMI Environmental Solutions, Inc. (U.S.)

12. Market Outlook and Opportunities

• Emerging Technologies
• Future Market Trends
• Investment Opportunities

13. Appendix

• List of Abbreviations
• Sources and References